TERPMED is a Small Collaborative Project within the “Food, Agriculture and Fisheries, and Biotechnology” theme of the Seventh Framework Programme of the European Commission. Specifically, it falls under the topic of FP7-KBBE-2008-3-1-01: "Plant natural products. Alternative sources for the synthesis of bioactive or industrial added value products.”
Plant secondary metabolites are an important source of therapeutic drugs or drug leads. The advent of genomic and metabolomic technologies has now made it possible to bring the field of plant natural products into the 21st century and replace serendipitous and haphazard finding by rational design and discovery. The TERPMED project is devoted to plant terpenes, the largest and most diverse group of plant natural products. In particular, TERPMED will focus on sesquiterpene lactones and phenolic diterpenes because of their high potential as novel human drugs for treating cancer and neurological disorders.